ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sobi to refile Gamifant following CHMP rejection pharmatimes
July 28, 2020Sobi has announced its intent to file for a re-examination of Gamifant (emapalumab) in Europe following negative opinion by the European Medicines Agency's human medicines committee.
Pharma Sources Insight January 2025
